Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
about
Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferationWater-refined solution structure of the human Grb7-SH2 domain in complex with the erbB2 receptor peptide pY1139Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsRegulation of stress granule dynamics by Grb7 and FAK signalling pathwayGrb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repressionPotential of phage-displayed peptide library technology to identify functional targeting peptidesGrowth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells.Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide.Progress towards the development of SH2 domain inhibitors.Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy.Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesisReceptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines.Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents.Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance.Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.GRB7 is required for triple-negative breast cancer cell invasion and survival.Kinesin 18A expression: clinical relevance to colorectal cancer progression.Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain.Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.Non-ATP-competitive kinase inhibitors - enhancing selectivity through new inhibition strategies.Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one?Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide.Grb7 protein RA domain oligomerization.
P2860
Q27648499-EE2F1C5A-A137-4536-8EAD-A4C7BC85BDD5Q27681182-52BA32AA-44A5-449D-8AF7-B8500708E006Q28484496-D90195B9-AEE4-40E6-B608-C50C1BAF8CA9Q28594685-EDFD219F-E25A-4A7A-B674-0AB73B782468Q33528957-38FF48EC-CCAA-48C9-BC07-B97A9A36DCFBQ33530848-FA17EA1A-B5B8-4910-839E-EF1C2F48BAC4Q33676758-B457B8C5-6EC4-47DF-9C59-A1DA5CC90BA3Q34065842-B581C3F5-1247-4D35-B56D-F96E3249615FQ34121550-365D5682-3CF1-4881-941F-E19A4FE435BFQ34130780-9AE8827C-E6E8-4B57-9D3B-9701CF643DAFQ34387280-D12FD3A1-F85B-4B78-B2FD-4C1A741E284DQ34581878-74A31BDD-EC4C-4F84-90C0-7D2A64560366Q35979251-12ED9077-CB43-4587-8991-13A99BF5807DQ36093867-413C3C48-E816-4196-95DC-460A7FF928CBQ36261762-865C137C-4273-4FDF-B9A6-AF6443202501Q36603829-FDB7E21E-6153-42B6-A9A5-2D251D873BA9Q36609570-0EA30B8B-98E1-4604-90A1-CB4BB86D2092Q36758884-460E9517-DC15-4AD5-9909-61CE71364933Q36964946-03414B9F-447E-4B0A-A41B-715DD9A21859Q37135451-BA3F3D63-474A-4012-B112-72471ADB7F1BQ37339045-4CE25443-F912-412A-8CC5-22E138FE5AB2Q37415599-7831B57E-CBEF-4A18-8168-C9914093DD46Q38078237-444DDBA5-8D17-4743-BD0F-D15974219994Q38370174-43C63B70-8E18-4B11-BA44-B2048D9E45F7Q38494545-BCDA2207-4786-4986-86FB-83B521AAAEE2Q38806090-F74533F8-AA8F-432D-A6E1-A1564F824F8EQ39030506-2CFC97B8-60B6-489C-B928-1F9209C911A9Q39187561-865CF729-68D9-49A6-9CA8-F1F3C327BD67Q39203618-4AD23C4A-3C5F-4C27-9632-6391ED2A2065Q39245130-74354DAB-454D-4B39-8BDC-2F2C371CB1C0Q39418443-4D32274D-475E-40C2-B4F8-9BA81D23C94CQ39456781-059964F2-E4AC-42B7-A248-69FE9F332A80Q39611073-A7211E6C-27D5-453E-B7BC-182F2DA1366FQ39690631-1B6CB42D-0AC8-424B-9301-D3C17E19588FQ42103874-9BC22FB8-8CE0-46A7-93C3-69D31BC7D667Q43878954-4C85932F-EDCD-4A68-A388-3694DF10A19BQ44853520-0327338C-1434-452A-A64B-4D5FF26F226AQ47094453-FB32124F-506A-4FD0-B580-625F139E362BQ47117237-FD5D3D73-01B1-4B6F-9181-F3FF79C94374Q48124298-95407D2F-1AAC-4EB2-901F-2B2174A69706
P2860
Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@en
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@nl
type
label
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@en
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@nl
prefLabel
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@en
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@nl
P2093
P2860
P356
P1476
Specific peptide ligand for Gr ...... pancreatic cancer metastasis.
@en
P2093
David N Krag
Kenichi Taguchi
Masaki Mori
Mitsuo Shimada
Shigeki Arii
Shinji Tanaka
Stephanie C Pero
P2860
P304
P356
10.1093/JNCI/DJJ105
P407
P577
2006-04-01T00:00:00Z